Respiratory Medicine
Volume 104, Issue 4 , Pages 557-563 , April 2010

A profile of volatile organic compounds in breath discriminates COPD patients from controls

  • J.J.B.N. Van Berkel

      Affiliations

    • Department of Health Risk Analysis and Toxicology, Faculty of Health, Medicine and Life Sciences, Research Institute NUTRIM, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • J.W. Dallinga

      Affiliations

    • Department of Health Risk Analysis and Toxicology, Faculty of Health, Medicine and Life Sciences, Research Institute NUTRIM, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • G.M. Möller

      Affiliations

    • Department of Respiratory Medicine, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands
    • Present address: Department of Respiratory Medicine, Leiden University Medical Centre, Leiden, the Netherlands.
    • ,
  • R.W.L. Godschalk

      Affiliations

    • Department of Health Risk Analysis and Toxicology, Faculty of Health, Medicine and Life Sciences, Research Institute NUTRIM, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • E.J. Moonen

      Affiliations

    • Department of Health Risk Analysis and Toxicology, Faculty of Health, Medicine and Life Sciences, Research Institute NUTRIM, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • E.F.M. Wouters

      Affiliations

    • Department of Respiratory Medicine, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands
    • Centre for Integrated Rehabilitation Organ Failure (CIRO), Horn, The Netherlands
    • ,
  • F.J. Van Schooten

      Affiliations

    • Department of Health Risk Analysis and Toxicology, Faculty of Health, Medicine and Life Sciences, Research Institute NUTRIM, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands
    • Corresponding Author InformationCorresponding author.

Received 16 June 2009 ,Accepted 21 October 2009.

References 

  1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007 Sep 1;370(9589):765–773
  2. Rutten-van Molken MP, Postma MJ, Joore MA, Van Genugten ML, Leidl R, Jager JC. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. Respir Med. 1999 Nov;93(11):779–787
  3. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001 Jun;163(7):1693–1722
  4. Kharitonov SA, Barnes PJ. Exhaled markers of inflammation. Curr Opin Allergy Clin Immunol. 2001 Jun;1(3):217–224
  5. Yamaya M, Sekizawa K, Ishizuka S, Monma M, Sasaki H. Exhaled carbon monoxide levels during treatment of acute asthma. Eur Respir J. 1999 Apr;13(4):757–760
  6. Montuschi P, Kharitonov SA, Barnes PJ. Exhaled carbon monoxide and nitric oxide in COPD. Chest. 2001 Aug;120(2):496–501
  7. Horvath I, MacNee W, Kelly FJ, Dekhuijzen PN, Phillips M, Doring G, et al. “Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999. Eur Respir J. 2001 Aug;18(2):420–430
  8. Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, Barnes PJ. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):369–373
  9. Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis of urine vapor and breath by gas–liquid partition chromatography. Proc Natl Acad Sci U S A. 1971 Oct;68(10):2374–2376
  10. Phillips M, Gleeson K, Hughes JM, Greenberg J, Cataneo RN, Baker L, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet. 1999 Jun 5;353(9168):1930–1933
  11. Phillips M, Cataneo RN, Condos R, Ring Erickson GA, Greenberg J, La Bombardi V, et al. Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis (Edinb). 2007 Jan;87(1):44–52
  12. Phillips M, Altorki N, Austin JH, Cameron RB, Cataneo RN, Greenberg J, et al. Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark. 2007;3(2):95–109
  13. Van Berkel JJ, Dallinga JW, Moller GM, Godschalk RW, Moonen E, Wouters EF, et al. Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jan 1;861(1):101–107
  14. Stein SE, Scott DR. Optimization and testing of mass-spectral library search algorithms for compound identification. J Am Soc Mass Spectrom. 1994 Sep;5(9):859–866
  15. Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector machines. Mach Learn. 2002;46(1–3):389–422
  16. Platt JC. Fast training of support vector machines using sequential minimal optimization. MIT Press; 1998;
  17. Miekisch W, Schubert JK, Noeldge-Schomburg GF. Diagnostic potential of breath analysis – focus on volatile organic compounds. Clin Chim Acta. 2004 Sep;347(1–2):25–39

PII: S0954-6111(09)00351-5

doi: 10.1016/j.rmed.2009.10.018

Respiratory Medicine
Volume 104, Issue 4 , Pages 557-563 , April 2010

Article Tools

* Image Usage & Resolution